Literature DB >> 9371706

Use of photoactivatable sphingolipid analogues to monitor lipid transport in mammalian cells.

M M Zegers1, J W Kok, D Hoekstra.   

Abstract

Photoactivatable derivatives of ceramide, glucosylceramide (GlcCer) and sphingomyelin {3-(p-azido-m-[125I]iodophenyl)propionylceramide, 3-(p-azido-m-[125I]iodophenyl)propionyl-GlcCer and 3-(p-azido-m-[125I]iodophenyl)propionylsphingomyelin} were synthesized in an attempt to identify compartment-specific proteins involved in sphingolipid sorting or metabolism. In HT29 and BHK cells the ceramide analogue entered the cell by monomeric diffusion, as evidenced by the probe's efficient internalization at low temperature (4 degrees C). In contrast, the photoactivatable GlcCer was internalized only at elevated temperatures (37 degrees C), presumably reflecting an endocytic mechanism of uptake. The photoactivatable ceramide was mainly metabolized to the corresponding sphingomyelin analogue, but small amounts of GlcCer and galactosylceramide were also synthesized. The newly synthesized photoreactive sphingomyelin was subsequently transported to the cell surface, a process that was effectively inhibited by the presence of brefeldin A. The incubation of cells with photoactivatable analogues at 4 degrees C, followed by illumination, led to the association of sphingolipid with a specific subset of proteins. The protein labelling pattern of ceramide differed from that of glucosylceramide. A further shift in labelling pattern was apparent when the cells were incubated with the lipid analogues at 37 degrees C. Moreover, most of the proteins labelled by photoreactive sphingomyelin seemed to be detergent-insoluble, which is indicative of a location in sphingolipid-rich microdomains at the plasma membrane. The potential of applying photoactivatable sphingolipids to further define and identify the role of distinct proteins in sphingolipid biosynthesis, transport and sorting, is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371706      PMCID: PMC1218946          DOI: 10.1042/bj3280489

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

Review 1.  Trafficking of glycosphingolipids in eukaryotic cells; sorting and recycling of lipids.

Authors:  D Hoekstra; J W Kok
Journal:  Biochim Biophys Acta       Date:  1992-12-11

2.  Activation of 5-[125I]iodonaphthyl-1-azide via excitation of fluorescent (N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)) lipid analogs in living cells. A potential tool for identification of compartment-specific proteins and proteins involved in intracellular transport and metabolism of lipids.

Authors:  A G Rosenwald; R E Pagano; Y Raviv
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

3.  Epithelial sphingolipid sorting allows for extensive variation of the fatty acyl chain and the sphingosine backbone.

Authors:  W van't Hof; J Silvius; F Wieland; G van Meer
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

4.  Brefeldin A promotes hydrolysis of sphingomyelin.

Authors:  C M Linardic; S Jayadev; Y A Hannun
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

5.  Brefeldin A-induced increase of sphingomyelin synthesis. Assay for the action of the antibiotic in mammalian cells.

Authors:  A Brüning; A Karrenbauer; E Schnabel; F T Wieland
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

6.  Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface.

Authors:  D A Brown; J K Rose
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

7.  Ceramide excluded from cell-free vesicular lipid transfer from endoplasmic reticulum to Golgi apparatus. Evidence for lipid sorting.

Authors:  P Moreau; C Cassagne; T W Keenan; D J Morré
Journal:  Biochim Biophys Acta       Date:  1993-02-23

8.  Effects of brefeldin A on sphingomyelin transport and lipid synthesis in BHK21 cells.

Authors:  K J Kallen; P Quinn; D Allan
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

9.  Sorting of sphingolipids in the endocytic pathway of HT29 cells.

Authors:  J W Kok; T Babia; D Hoekstra
Journal:  J Cell Biol       Date:  1991-07       Impact factor: 10.539

10.  Forskolin inhibits and reverses the effects of brefeldin A on Golgi morphology by a cAMP-independent mechanism.

Authors:  J Lippincott-Schwartz; J Glickman; J G Donaldson; J Robbins; T E Kreis; K B Seamon; M P Sheetz; R D Klausner
Journal:  J Cell Biol       Date:  1991-02       Impact factor: 10.539

View more
  6 in total

Review 1.  On the biogenesis of the myelin sheath: cognate polarized trafficking pathways in oligodendrocytes.

Authors:  H de Vries; D Hoekstra
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

Review 2.  Glycolipid transfer proteins.

Authors:  Rhoderick E Brown; Peter Mattjus
Journal:  Biochim Biophys Acta       Date:  2007-01-24

Review 3.  Mechanisms and functional features of polarized membrane traffic in epithelial and hepatic cells.

Authors:  M M Zegers; D Hoekstra
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

4.  Anchoring of protein kinase A-regulatory subunit IIalpha to subapically positioned centrosomes mediates apical bile canalicular lumen development in response to oncostatin M but not cAMP.

Authors:  Kacper A Wojtal; Dick Hoekstra; Sven C D van Ijzendoorn
Journal:  Mol Biol Cell       Date:  2007-05-09       Impact factor: 4.138

5.  Actin filaments and microtubules are involved in different membrane traffic pathways that transport sphingolipids to the apical surface of polarized HepG2 cells.

Authors:  M M Zegers; K J Zaal; S C van IJzendoorn; K Klappe; D Hoekstra
Journal:  Mol Biol Cell       Date:  1998-07       Impact factor: 4.138

6.  Human glycolipid transfer protein (GLTP) genes: organization, transcriptional status and evolution.

Authors:  Xianqiong Zou; Taeowan Chung; Xin Lin; Margarita L Malakhova; Helen M Pike; Rhoderick E Brown
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.